There are 2949 resources available
Optimising clinical outcomes: the case for personalised medicine in ovarian cancer
Presenter: Ignace Vergote
Session: AstraZeneca - Redefining long-term outcomes in the era of personalised medicine: Maintenance treatment in newly diagnosed ovarian cancer
Resources:
Webcast
Panel discussion
Presenter: Ignace Vergote
Session: AstraZeneca - Redefining long-term outcomes in the era of personalised medicine: Maintenance treatment in newly diagnosed ovarian cancer
Resources:
Webcast
Summary and meeting close
Presenter: Ana Oaknin
Session: AstraZeneca - Redefining long-term outcomes in the era of personalised medicine: Maintenance treatment in newly diagnosed ovarian cancer
Resources:
Webcast
Predictors of treatment outcomes in patients with advanced ovarian cancer
Presenter: Bradley Monk
Session: GSK - Treatment options for women with advanced ovarian cancer: Evaluating the evidence
Resources:
Webcast
Evaluating first-line maintenance therapy options
Presenter: Antonio González Martín
Session: GSK - Treatment options for women with advanced ovarian cancer: Evaluating the evidence
Resources:
Webcast
The role of genetic testing in the treatment decision-making process
Presenter: Kathleen Moore
Session: GSK - Treatment options for women with advanced ovarian cancer: Evaluating the evidence
Resources:
Webcast
PARPi in the treatment of recurrent disease
Presenter: Jonathan Ledermann
Session: GSK - Treatment options for women with advanced ovarian cancer: Evaluating the evidence
Resources:
Webcast
Welcome and introductions
Presenter: Eva Ciruelos
Session: AstraZeneca - HER tomorrow in HER2+ metastatic breast cancer
Resources:
Webcast
HER past: Looking back on two decades of HER2-targeted therapy
Presenter: Fatima Cardoso
Session: AstraZeneca - HER tomorrow in HER2+ metastatic breast cancer
Resources:
Webcast
HER new potential: New advances in HER2+ breast cancer treatment
Presenter: Erika Hamilton
Session: AstraZeneca - HER tomorrow in HER2+ metastatic breast cancer
Resources:
Webcast